Back to search

Sweden· SE-20220131000173

Tapimio Depot 50 mg Depottablett

A medicinal product containing tapentadol, registered in Sweden by Neuraxpharm Sweden AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedTapimio Depot 50 mg DepottablettATC—REGISTER NO.SE-20220131000173PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Tapentadol
Manufacturer
Neuraxpharm Sweden AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20220131000173

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tapentadol in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tapentadol products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Palexia, Palexia Retard
  • Belgium · Palexia, Palexia Retard
  • Cyprus · Dolten, Dolten Retard
  • Czechia · Apeneta, Dolupren
  • Germany · Palexia, Palexia Akutschmerz
  • Denmark · Palexia, Palexia Depot
  • Estonia · Tapemed Retard
  • Spain · Palexia, Palexia Retard
  • United Kingdom (Northern Ireland) · Ationdo, Ationdo Sr
  • Greece · Dolupren, Dolupren Ir
  • Croatia · Apeneta, Dolten
  • Hungary · Adoben
  • Ireland · Apeneta, Palexia
  • Iceland · Tapentadol Stada
  • Italy · Palexia, Taboxea
  • Luxembourg · Palexia, Palexia Retard
  • Malta · Dolten, Dolten Retard
  • Netherlands · Palexia, Palexia Retard
  • Norway · Palexia, Palexia Depot
  • Poland · Adoben, Binatta
  • Portugal · Ationdo, Palexia
  • Romania · Dolten
  • Slovenia · Apeneta, Palexia
  • Slovakia · Apeneta, Dolten

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7c4faf2-2836-40a4-bb2c-c042e43d538b
GET /v1/drugs/f7c4faf2-2836-40a4-bb2c-c042e43d538b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "20220131000173",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20220131000173",
  "product_doc_link": "https://docetp.mpa.se/LMF/Tapimio%20Depot%20Prolonged-release%20tablet%20SmPC_09001bee82ec55b4.pdf"
}

See everything about tapentadol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.